Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.25
+0.960011.58%
Post-market: 9.22-0.0294-0.32%19:59 EDT
Volume:22.37M
Turnover:211.18M
Market Cap:2.20B
PE:15.42
High:9.81
Open:9.47
Low:8.86
Close:8.29
52wk High:25.67
52wk Low:7.21
Shares:238.00M
Float Shares:233.86M
Volume Ratio:1.07
T/O Rate:9.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):0.6000
ROE:35.56%
ROA:21.50%
PB:4.61
PE(LYR):15.42

Loading ...

Adma Biologics addresses misleading report by Culper Research

TIPRANKS
·
Mar 25

ADMA Biologics : Short Report Appears Premised on Speculative Assertions Derived From Unidentified and Unreliable Sources

THOMSON REUTERS
·
Mar 25

ADMA Biologics Inc: Taking Appropriate Steps to Review Assertions in the Short Report

THOMSON REUTERS
·
Mar 25

Culper Research short Adma Biologics, says reported growth ‘a fiction’

TIPRANKS
·
Mar 25

BRIEF-Culper Research Says We Are Short ADMA Biologics

Reuters
·
Mar 25

Assessing ADMA Biologics (ADMA) Valuation After Fresh Analyst Upgrades And Strong Buy Sentiment

Simply Wall St.
·
Mar 23

ADMA Biologics President and CEO Adam S. Grossman disposes of USD 318,360 in common shares

Reuters
·
Mar 18

FDA-Approved Yield Boost For ASCENIV Might Change The Case For Investing In ADMA Biologics (ADMA)

Simply Wall St.
·
Mar 17

Insider Confidence Surges as ADMA Biologics Director Makes Bold Move

TIPRANKS
·
Mar 10

Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside?

Simply Wall St.
·
Mar 05

Stock Track | ADMA Biologics Soars 5.20% Intraday on $125 Million Share Repurchase Announcement with JPMorgan

Stock Track
·
Mar 02

ADMA Biologics launches $125 million accelerated share repurchase with JPMorgan

Reuters
·
Mar 02

ADMA Biologics Files Initial Beneficial Ownership Statement for CFO and Treasurer Terry Kohler

Reuters
·
Feb 27

BRIEF-ADMA Biologics Says Brad Tade Is Retiring As Chief Financial Officer

Reuters
·
Feb 26

ADMA Biologics Inc: Tade Will Serve as a Consultant to the Company

THOMSON REUTERS
·
Feb 26

ADMA Biologics Inc - Terry Kohler to Succeed Brad Tade as CFO - SEC Filing

THOMSON REUTERS
·
Feb 26

Earnings Flash (ADMA) ADMA Biologics Posts Q4 EPS $0.20, vs. FactSet Est of $0.19

MT Newswires Live
·
Feb 26

GUIDANCE: (ADMA) ADMA Biologics Expects 2026 Revenue to Exceed $635M, vs. FactSet Est of $633.8M

MT Newswires Live
·
Feb 26

ADMA Biologics Q4 Adj. EPS $0.21 Beats $0.18 Estimate, Sales $139.163M Miss $139.400M Estimate

Benzinga
·
Feb 26

CORRECTED-BRIEF-ADMA Biologics Q4 Revenue USD 139.2 Million

Reuters
·
Feb 26